Therapeutic options shown on this site are based on EMA drug approvals. Availability of drugs may vary in your country.

The Lung-Carcinoma-Portal is supported by

Information services like the Lung-Carcinoma-Portal would be impossible to provide without the financial support of the pharmaceutical industry. Accordingly, we thank the pharmaceutical companies mentioned here for their support. We would also like to remind site visitors that QuIP is a neutral provider of relevant and evidence-based content for pathology practitioners.